C. Voegele

发表

ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry

J. Hopper, E. John, M. Southey, 2016, PloS one.

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study

J. Hopper, E. John, M. Southey, 2014, Breast Cancer Research.

CASP9 germline mutation in a family with multiple brain tumors

B. Klink, H. Ohgaki, D. Capper, 2018, Brain pathology.

Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing

Z. Herceg, J. McKay, N. Fernandez-Jimenez, 2016, Oncotarget.

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

R. Malekzadeh, E. Weiderpass, H. Poustchi, 2020, EBioMedicine.

Multigene testing of moderate-risk genes: be mindful of the missense

E. John, M. Southey, S. Tavtigian, 2016, Journal of Medical Genetics.

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer

E. Weiderpass, G. Byrnes, M. Foll, 2019, EBioMedicine.

Detection of BRCA1/2 mutations in breast cancer patients from Thailand and Pakistan

S. Sangrajrang, V. Gaborieau, O. Sinilnikova, 2012, Clinical genetics.

Rare mutations in XRCC2 increase the risk of breast cancer.

Daniel J. Park, J. Benítez, G. Giles, 2012, American journal of human genetics.

Development of a Custom NGS Panel for the Determination of Bladder Cancer Risk

S. Ouerhani, M. Chebil, C. Voegele, 2021 .

Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden

Aurélie A G Gabriel, J. Witte, P. Brennan, 2022, Journal of the National Cancer Institute.

Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA

P. Brennan, L. Forétova, E. Fabianova, 2020, EBioMedicine.

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Cancer

H. Clevers, S. Lantuejoul, J. G. van den Berg, 2022, bioRxiv.

First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali

P. Hainaut, Pareena G. Lawrence, E. Gormally, 2023, Diagnostics.

Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus

Catherine Voegele, Tú Nguyen-Dumont, Federica Gemignani, 2009, BMC Genetics.

Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma

F. Zoulim, U. d’Alessandro, C. Brochier-Armanet, 2020, JHEP reports : innovation in hepatology.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Aurélie A G Gabriel, N. Le Stang, N. Girard, 2019, Nature Communications.

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.

Daniel J. Park, Shankaracharya, G. Giles, 2014, Cancer discovery.

RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study

J. Hopper, E. John, M. Southey, 2012, PloS one.

Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

J. Hopper, E. John, M. Southey, 2011, Breast Cancer Research.

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Alun Thomas, Sue Healey, John L Hopper, 2009, American journal of human genetics.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

S. Cross, P. Fasching, C. Vachon, 2016, Journal of Medical Genetics.

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer

G. Byrnes, M. Foll, G. Scelo, 2020, Cancers.

Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma

P. Brennan, D. Zaridze, A. Mukeria, 2016, Scientific Reports.

Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

X. Castells, A. Heguy, J. Zavadil, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses

Erik N. Bergstrom, P. Courtiol, C. Maussion, 2021, bioRxiv.

Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden

C. Amos, V. Gaborieau, M. Johansson, 2021, medRxiv.

A molecular phenotypic map of malignant pleural mesothelioma

L. Fernandez-Cuesta, M. Foll, A. Di Genova, 2022, bioRxiv.

TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors.

P. Kleihues, H. Ohgaki, W. Paulus, 2014, The American journal of pathology.

Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues

J. Zavadil, M. Olivier, C. Pérez-Plasencia, 2015, PloS one.

Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice

J. Zavadil, C. Flechtenmacher, S. Caldeira, 2018, PLoS pathogens.

Epstein - Barr Virus Transforming Protein LMP-1 Alters B Cells Gene Expression by Promoting Accumulation of the Oncoprotein ΔNp73α

B. Bartosch, M. Tommasino, J. McKay, 2013, PLoS pathogens.

Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort

S. Boussetta, S. Ouerhani, M. Chebil, 2021, Molecular Biology Reports.

Rare Mutations in XRCC 2 Increase the Risk of Breast Cancer

J. Benítez, G. Giles, S. Buys, 2022 .

A molecular map of lung neuroendocrine neoplasms

Matthieu Foll, Catherine Voegele, Aurélie A G Gabriel, 2020, GigaScience.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

P. Courtiol, C. Maussion, N. Le Stang, 2023, Nature Genetics.

Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data

Paul Brennan, Elisabeth Brambilla, Matthieu Foll, 2019, bioRxiv.

A universal open-source Electronic Laboratory Notebook

James McKay, Catherine Voegele, Baptiste Bouchereau, 2013, Bioinform..

Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015

Sugiyanto, Asma Abdul Rahman, C. Lemmen, 2016, BMC Proceedings.

Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysis

D. Trégouët, T. Galesloot, M. Johansson, 2023, medRxiv.

A Laboratory Information Management System (LIMS) for a high throughput genetic platform aimed at candidate gene mutation screening

Alun Thomas, Catherine Voegele, Sean V. Tavtigian, 2007, Bioinform..

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study

E. John, M. Southey, S. Tavtigian, 2014, Breast Cancer Research.

Understanding the Role of the Immune System in the Development of Cancer: New Opportunities for Population-Based Research

C. Marsit, K. Overvad, E. Weiderpass, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.

I. B. Borel Rinkes, J. Korving, H. Begthel, 2023, Cancer cell.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

S. Cross, P. Fasching, C. Vachon, 2016, Journal of Medical Genetics.

A universal open-source Electronic Laboratory Notebook

C. Voegele, P. Damiecki, J. Mckay, 2013, Bioinform..

Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis

J. Mckay, T. Galesloot, M. Johansson, 2023, International journal of epidemiology.